NMPA Approval

Nalmefene Hydrochloride Injection

Approval Number

国药准字H20183012

Company成都苑东生物制药股份有限公司

Registration Date

November 21, 2022

Previous Approval Numbers

国药准字H20183012

Drug Information

Generic Name

盐酸纳美芬注射液

Brand Name

施凡

Dosage Form

注射剂

Strength

1ml：0.1mg（以C21H25NO3计）

Drug Type

化学药品

Registration Date

November 21, 2022

Company Information

Applicant Company

Company Name成都苑东生物制药股份有限公司

Company Address

成都高新区西源大道8号

Manufacturing Company

Company Name成都苑东生物制药股份有限公司

Company Address

成都高新区西源大道8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸纳美芬注射液 - NMPA 批准文号 | MedPath